Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research and development of new tuberculosis vaccines: a review
Lewis K. Schrager, Rebecca C. Harris, Johan Vekemans
F1000Research (2018) Vol. 7, pp. 1732-1732
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
Dereck Tait, Mark Hatherill, Olivier Van Der Meeren, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 25, pp. 2429-2439
Open Access | Times Cited: 428
Accelerating research and development of new vaccines against tuberculosis: a global roadmap
Frank Cobelens, Rajinder Kumar Suri, Michelle E. H. Helinski, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 4, pp. e108-e120
Open Access | Times Cited: 52
Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity
Laura Pöyhönen, Jacinta Bustamante, Jean‐Laurent Casanova, et al.
Journal of Clinical Immunology (2019) Vol. 39, Iss. 4, pp. 376-390
Open Access | Times Cited: 70
Potential impact of tuberculosis vaccines in China, South Africa, and India
Rebecca C. Harris, Tom Sumner, Gwenan M. Knight, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 564
Open Access | Times Cited: 52
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
Sasha E. Larsen, Brittany D. Williams, Maham Rais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Differential skewing of donor-unrestricted and γδ T cell repertoires in tuberculosis-infected human lungs
Paul Ogongo, Adrie J. C. Steyn, Farina Karim, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 1, pp. 214-230
Open Access | Times Cited: 44
Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections
Jan Poolman
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 43
Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development
Liqin Shi, Ruiqi Gu, Jinzhao Long, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
DNA Subunit Vaccine and Recombinant BCG Based on Mycobacterial Lipoprotein LprO Enhance Anti-Tuberculosis Protection in the Lungs of Mice
Weili Huang, Shuqin Xu, Li‐Fang Shen, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 400-400
Open Access
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)
Marzio Pennisi, Giulia Russo, Giuseppe Sgroi, et al.
BMC Bioinformatics (2019) Vol. 20, Iss. S6
Open Access | Times Cited: 39
Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases
Lampouguin Yenkoidiok-Douti, Christopher M. Jewell
ACS Biomaterials Science & Engineering (2020) Vol. 6, Iss. 2, pp. 759-778
Open Access | Times Cited: 36
Prediction of a novel synthetic peptide vaccine against tuberculosis and validation of its immunogenicity
Dongdong Zhang, Donghui Wang, Shu Jiang, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114531-114531
Closed Access
PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response
Eliza Kramarska, Flavia Squeglia, Flavio De Maio, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 161-161
Open Access | Times Cited: 23
Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines
Jyoti Yadav, Sonali Verma, Darshna Chaudhary, et al.
Current Pharmaceutical Biotechnology (2019) Vol. 20, Iss. 6, pp. 446-458
Closed Access | Times Cited: 29
Addressing mechanism bias in model-based impact forecasts of new tuberculosis vaccines
Mario Tovar, Yamir Moreno, Joaquín Sanz
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Mycobacterial virulence: impact on immunogenicity and vaccine research
Vera Marie Kroesen, Jan Madacki, Wafa Frigui, et al.
F1000Research (2019) Vol. 8, pp. 2025-2025
Open Access | Times Cited: 22
CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial
Tereza Masonou, David A. Hokey, Timothy Lahey, et al.
PLoS ONE (2019) Vol. 14, Iss. 5, pp. e0217091-e0217091
Open Access | Times Cited: 20
6,6′-Aryl trehalose analogs as potential Mincle ligands
Omer K. Rasheed, George Ettenger, Cassandra Buhl, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 14, pp. 115564-115564
Open Access | Times Cited: 20
Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity
Jieling Lim, Vanessa Hui Qi Koh, Su Lei Sharol Cho, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 18
New Developments and Insights in the Improvement of Mycobacterium tuberculosis Vaccines and Diagnostics Within the End TB Strategy
Juan Ignacio García, Anna Allué‐Guardia, Radhika P. Tampi, et al.
Current Epidemiology Reports (2021) Vol. 8, Iss. 2, pp. 33-45
Open Access | Times Cited: 15
Strategies Employed to Evade the Host Immune Response and the Mechanism of Drug Resistance in Mycobacterium tuberculosis: In Search of Finding New Targets
Zahoor Ahmad, Manzoor Ahmad Mir, Bashir Ahmad Sheikh, et al.
Current Pharmaceutical Biotechnology (2021) Vol. 23, Iss. 14, pp. 1704-1720
Closed Access | Times Cited: 12
Tuberculosis vaccines: Rising opportunities
Johan Vekemans, Katherine L. O’Brien, Jeremy Farrar
PLoS Medicine (2019) Vol. 16, Iss. 4, pp. e1002791-e1002791
Open Access | Times Cited: 10
RNA Microarray-Based Comparison of Innate Immune Phenotypes between Human THP-1 Macrophages Stimulated with Two BCG Strains
Gabriela Molina-Olvera, Claudia Ivette Rivas-Ortiz, Alejandro Schcolnik‐Cabrera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4525-4525
Open Access | Times Cited: 6
Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice
Ying Waeckerle‐Men, Zuzanna K. Kotkowska, Géraldine Bono, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Exacting Edward Jenner’s revenge: The quest for a new tuberculosis vaccine
Steven A. Porcelli, William R. Jacobs
Science Translational Medicine (2019) Vol. 11, Iss. 490
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top